» Articles » PMID: 33338686

Optimizing Omalizumab Dosing in Severe Asthma-the Exploration of Therapeutic Drug Monitoring

Overview
Date 2020 Dec 18
PMID 33338686
Citations 4
Authors
Affiliations
Soon will be listed here.
Citing Articles

Evidence-Based Approach of Biologic Therapy in Bronchial Asthma.

Liaqat A, Mason M, Foster B, Gregory G, Patel A, Barlas A J Clin Med. 2023; 12(13).

PMID: 37445357 PMC: 10342309. DOI: 10.3390/jcm12134321.


Towards precision drug therapy in asthma.

van Boven J Ann Transl Med. 2022; 10(17):921.

PMID: 36172113 PMC: 9511191. DOI: 10.21037/atm-22-3803.


Cumulative corticosteroid-sparing effect of anti-interleukin-5/5Ra in eosinophilic asthma.

Kroes J, Zielhuis S, de Jong K, Hashimoto S, Sont J, Zielhuis S Eur Respir J. 2022; 60(5).

PMID: 35595317 PMC: 9630606. DOI: 10.1183/13993003.02983-2021.


Evaluation of Real-Life Investigational Use of Enoximone in Asthma, the Third Step in Drug Repurposing: A Preliminary Report.

Beute J, Boermans P, Kleinjan A Can Respir J. 2021; 2021:7456208.

PMID: 34760031 PMC: 8575614. DOI: 10.1155/2021/7456208.